Where CRO Consolidation May Take Us in 2012

According to Ciaran Murray, the CEO of Icon, large-scale CRO consolidation will not be at the level of past years in 2012.  According to Murray, the industry will take a step back and digest the moves from previous years, although companies will still be active in small acquisitions.  The recent acquisitions have put some smaller companies in the position to compete with the major players in the industry.  Look at what he had to say about the industry consolidation and the continued clinical outsourcing of pharma here. Our goal at Pearl is to continue to provide high value service to all our clients involved in clinical research, and continue to provide not only outstanding IRB services, but also other niche wrap around clinical services.